SCHEMBL25820557

SCHEMBL25820557

Cc1cccc(Cl)c1COc1cccc(OCCN)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.43
NOS1 P29475 1/20 0.43
NOS2 P35228 1/20 0.43
TAAR1 Q96RJ0 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SLC22A12 Q96S37 3/20 0.40
LTA4H P09960 1/20 0.38
PLA2G2A P14555 1/20 0.38
DPP4 P27487 1/20 0.38
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
PIK3CG P48736 1/20 0.37
PRKDC P78527 1/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
MAOB P27338 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29818789 0.90 SMN1; SMN2 (0.51) NOS3NOS1NOS2TAAR1SMN1; SMN2
SCHEMBL2206066 0.90 SMN1; SMN2 (0.51) NOS3NOS1NOS2TAAR1SMN1; SMN2
SCHEMBL29818723 0.90 TAAR1 (0.48) NOS3NOS1NOS2TAAR1SLC22A12
SCHEMBL2205356 0.90 TAAR1 (0.48) NOS3NOS1NOS2TAAR1SLC22A12
SCHEMBL25823652 0.83 NPC1 (0.42) NOS3NOS1NOS2TAAR1SMN1; SMN2
SCHEMBL25825928 0.83 HTR1B (0.47) SMN1; SMN2KMT2ASLC22A12DRD2DRD4
SCHEMBL13881826 0.82 MEN1 (0.44) NOS3NOS1NOS2TAAR1SMN1; SMN2
SCHEMBL19291686 0.78 CCNB2 (0.53) NOS3NOS1NOS2TAAR1KMT2A
SCHEMBL4568939 0.77 SMN1; SMN2 (0.51) SMN1; SMN2MEN1KMT2APIK3CDPIK3CA
SCHEMBL9107098 0.76 TAAR1 (0.70) TAAR1LTA4HPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230218549-A1 ALKOXY COMPOUNDS FOR DISEASE TREATMENT ACUCELA INC. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230218549-A1 ALKOXY COMPOUNDS FOR DISEASE TREATMENT ALDH1A2, CLN6, AGER NOS3 1001/4885NOS1 1659/4885NOS2 1900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.